Crossref journal-article
Proceedings of the National Academy of Sciences
Proceedings of the National Academy of Sciences (341)
Abstract

The recurring translocation t(11;16)(q23;p13.3) has been documented only in cases of acute leukemia or myelodysplasia secondary to therapy with drugs targeting DNA topoisomerase II. We show that the MLL gene is fused to the gene that codes for CBP (CREB-binding protein), the protein that binds specifically to the DNA-binding protein CREB (cAMP response element-binding protein) in this translocation. MLL is fused in-frame to a different exon of CBP in two patients producing chimeric proteins containing the AT-hooks, methyltransferase homology domain, and transcriptional repression domain of MLL fused to the CREB binding domain or to the bromodomain of CBP. Both fusion products retain the histone acetyltransferase domain of CBP and may lead to leukemia by promoting histone acetylation of genomic regions targeted by the MLL AT-hooks, leading to transcriptional deregulation via aberrant chromatin organization. CBP is the first partner gene of MLL containing well defined structural and functional motifs that provide unique insights into the potential mechanisms by which these translocations contribute to leukemogenesis.

Bibliography

Sobulo, O. M., Borrow, J., Tomek, R., Reshmi, S., Harden, A., Schlegelberger, B., Housman, D., Doggett, N. A., Rowley, J. D., & Zeleznik-Le, N. J. (1997). MLL is fused to CBP, a histone acetyltransferase, in therapy-related acute myeloid leukemia with a t(11;16)(q23;p13.3). Proceedings of the National Academy of Sciences, 94(16), 8732–8737.

Authors 10
  1. Olatoyosi M. Sobulo (first)
  2. Julian Borrow (additional)
  3. Ronald Tomek (additional)
  4. Shalini Reshmi (additional)
  5. Alanna Harden (additional)
  6. Brigitte Schlegelberger (additional)
  7. David Housman (additional)
  8. Norman A. Doggett (additional)
  9. Janet D. Rowley (additional)
  10. Nancy J. Zeleznik-Le (additional)
References 54 Referenced 260
  1. J D Rowley, S Reshmi, O Sobulo, T Musvee, J Anastasi, S Raimondi, N R Schneider, J C Barredo, B Schlegelberger, F Behm, N A Doggett, J Borrow, N Zeleznik-Le Blood 90, 535–541 (1997). / Blood by Rowley J D (1997)
  2. 10.1073/pnas.88.23.10735
  3. G Cimino, D T Moir, O Canaani, K Williams, W M Crist, S Katzav, L Cannizzaro, B Lange, P C Nowell, C M Croce, E Canaani Cancer Res 51, 6712–6714 (1991). / Cancer Res by Cimino G (1991)
  4. 10.1038/ng1092-113
  5. 10.1016/0092-8674(92)90602-9
  6. 10.1016/0092-8674(92)90603-A
  7. J D Rowley Seminars in Cancer Biology, ed T H Rabbitts (Academic, London), pp. 377–385 (1993). / Seminars in Cancer Biology by Rowley J D (1993)
  8. 10.1056/NEJM199309233291302
  9. 10.1002/gcc.2870130202
  10. 10.1182/blood.V81.12.3197.3197
  11. 10.1182/blood.V82.12.3705.3705
  12. C A Felix, B J Lange, M R Hosler, J Fertala, M A Bjornsti Cancer Res 55, 4287–4292 (1995). / Cancer Res by Felix C A (1995)
  13. P H Domer, D R Head, N Renganathan, S C Raimondi, E Yang, M Atlas Leukemia 9, 1305–1312 (1995). / Leukemia by Domer P H (1995)
  14. 10.1182/blood.V83.10.2780.2780
  15. 10.1016/S0021-9258(19)38926-4
  16. 10.1073/pnas.90.16.7884
  17. 10.1073/pnas.90.13.6350
  18. 10.1073/pnas.91.22.10610
  19. 10.1073/pnas.92.26.12160
  20. 10.1046/j.1365-313X.1993.04010137.x
  21. 10.1073/pnas.92.21.9737
  22. 10.1038/378505a0
  23. K L Wydner, S Bhattacharya, R Eckner, J B Lawrence, D M Livingstone Genomics 30, 395–396 (1995). / Genomics by Wydner K L (1995)
  24. 10.1038/376348a0
  25. 10.1038/ng0996-33
  26. 10.1038/370223a0
  27. 10.1038/370226a0
  28. A J Bannister, T Oehler, D Wilhelm, P Angel, T Kouzarides Oncogene 11, 2509–2514 (1995). / Oncogene by Bannister A J (1995)
  29. 10.1101/gad.10.5.528
  30. 10.1126/science.275.5299.523
  31. 10.1038/382319a0
  32. 10.1016/S0092-8674(00)82001-2
  33. 10.1038/384641a0
  34. 10.1001/archpedi.1963.02080040590010
  35. 10.1002/ajmg.1320560125
  36. 10.3109/10428199209053586
  37. 10.1200/JCO.1993.11.12.2370
  38. Doggett N. A. Coogwin L. A. Tesmer J. G. Meincke L. J. Bruce D. C. Clark L. M. Altherr M. R. Ford A. A. Chi H. C. & Murrone B. L. (1995) Nature (London) Suppl. 377 335–365.
  39. 10.1073/pnas.87.23.9358
  40. 10.1182/blood.V86.9.3613.bloodjournal8693613
  41. 10.1056/NEJM199602293340916
  42. 10.1089/dna.1995.14.475
  43. 10.1038/365855a0
  44. 10.1073/pnas.89.24.11794
  45. 10.1182/blood.V87.7.2649.bloodjournal8772649
  46. Strissel P. L. Hart C. Harden A. Rowley J. D. & Zeleznik-Le N. J. (1996) Blood Suppl. 1 250 (abstr.).
  47. 10.1016/S0092-8674(00)81063-6
  48. 10.1093/nar/20.10.2603
  49. 10.1016/0092-8674(92)90191-E
  50. 10.1016/S0092-8674(00)81269-6
  51. 10.1126/science.271.5257.1873
  52. 10.1182/blood.V89.11.3945
  53. Satake N. Ishida Y. Otoh Y. Hinohara S. Kobayashi H. Sakashita A. Maseki N. & Kaneko Y. (1997) Genes Chromosomes Cancer in press.
  54. 10.1006/geno.1997.4699
Dates
Type When
Created 23 years, 1 month ago (July 26, 2002, 10:35 a.m.)
Deposited 3 years, 2 months ago (June 6, 2022, 5:28 p.m.)
Indexed 1 week, 2 days ago (Aug. 19, 2025, 6:01 a.m.)
Issued 28 years ago (Aug. 5, 1997)
Published 28 years ago (Aug. 5, 1997)
Published Online 28 years ago (Aug. 5, 1997)
Published Print 28 years ago (Aug. 5, 1997)
Funders 0

None

@article{Sobulo_1997, title={MLL is fused to CBP, a histone acetyltransferase, in therapy-related acute myeloid leukemia with a t(11;16)(q23;p13.3)}, volume={94}, ISSN={1091-6490}, url={http://dx.doi.org/10.1073/pnas.94.16.8732}, DOI={10.1073/pnas.94.16.8732}, number={16}, journal={Proceedings of the National Academy of Sciences}, publisher={Proceedings of the National Academy of Sciences}, author={Sobulo, Olatoyosi M. and Borrow, Julian and Tomek, Ronald and Reshmi, Shalini and Harden, Alanna and Schlegelberger, Brigitte and Housman, David and Doggett, Norman A. and Rowley, Janet D. and Zeleznik-Le, Nancy J.}, year={1997}, month=aug, pages={8732–8737} }